• Blog
  • Epigenetics Market Report

    Epigenetics Market Report

    Epigenetics Market Report
    Report code - SRHL208 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Epigenetics Market, Dynamics, and Market Analysis
    See more...

    Impact of COVID-19 on Epigenetics Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Epigenetics Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Epigenetics Market is projected to grow from USD 5.9 billion in 2020 to USD 17.2 billion by 2026 at a CAGR of over 19.5% during the forecast period.

    Figure: Global Epigenetics Market Size, 2020-2026 (USD Billion)

    Epigenetics-Market-Forecast

    Wish to receive a full scope of the report? Click Here…

    What is Epigenetics?

    Epigenetics is referred to a stream of genetics that involves the study of physiological and cellular trait variations initiated by external or ecological aspects, which turns genes on and off and affects the cellular ability to read the genes without being impacted by changes in genotype. It results in changes in the phenotype of an organism rather than the genotype, where the underlying RNA or DNA sequence remains unchanged. Epigenetic alterations are vital for development as they are dynamic and change as per the surrounding environment stimuli.

    Key Players

    Key players operating in the global epigenetics market are-

    • Illumina, Inc. (The US),
    • Merck Sharp & Dohme Corp (The US),
    • Qiagen (Germany),
    • F. Hoffmann-La Roche Ltd. (Switzerland),
    • Eisai Co., Ltd. (Japan),
    • Novartis AG (Switzerland),
    • Abcam plc (UK),
    • Diagenode Diagnostics (Belgium),
    • Active Motif (The US),
    • Zymo Research Corporation (The US), and
    • CellCentric (UK).

    Market Dynamics

    The growing prevalence of cancer and other chronic diseases coupled with the increasing aging population is expected to bolster the product demand.

    • The increasing need to understand epigenetic modifications at the molecular level and the advancement of therapeutic solutions are likely to encourage government organizations to fund R&D programs, further bolstering the market growth.
    • Furthermore, various initiatives such as the Epidemiology and Genomics Research Program (EGRP) provide incentives to research activities for product innovation that are working towards an understanding of cancer causes and their related outcomes.

    Segment Analysis

    Product Trends

    Based on product, the global epigenetics market has been segmented into reagents, kits, instruments, enzymes, and services.

    • Among these, the reagents segment garnered the highest market share in 2020 and is likely to register a healthy CAGR during the assessment period.
    • Histone and DNA modifiers are the most common types of reagents used for epigenetics and are predominantly used for treating various medical conditions.

    Regional Trends

    By region, the North American market accounted for the largest market share of over 40% in 2020 and is likely to grow at a steady CAGR during the review period.

    • This can be attributed to significant funding for research activities on epigenetics in the US and the presence of a large number of key healthcare companies, thus accelerates the regional market growth.
    • Also, ongoing developments in the diagnostic procedures and presence of modern healthcare facilities are positively influencing the growth of the regional market.

    COVID-19 Impact on Global Epigenetics Market

    The COVID-19 pandemic has moderately affected the epigenetics industry. Few therapeutic combinations have been studies to cure this viral infection. Researchers have analyzed how epigenetics may prevent viral proliferation so that vaccines and therapeutics for COVID- 19 can be synthesized to specifically target replicating mechanisms of a virus. This, in turn, positively stimulates market growth.

    Critical Questions Answered in the Report

    • What are the key trends in the global epigenetics market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global epigenetics market?
    • What are the key strategies adopted by the major vendors to lead in the global epigenetics market?
    • What is the market share of the top vendors?

    Get the full scope of the report here....

    Target Audience

    The following is a list of the customers that the Epigenetics market aims to convert the most:

    • Epigenetics treatment companies
    • Hospitals
    • Diagnostic Centers And Laboratories
    • Cancer organizations
    • Research Centers & Organizations

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The epigenetics market is expected to reach USD 17.2 billion in the foreseeable future.

    Illumina, Inc. (The US), Merck Sharp & Dohme Corp (The US), Qiagen (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Eisai Co., Ltd. (Japan), Novartis AG (Switzerland), Abcam plc (UK), Diagenode Diagnostics (Belgium), Active Motif (The US), Zymo Research Corporation (The US), and CellCentric (UK) are among the key players in the epigenetics market.

    The epigenetics market is expected to witness an impressive growth of 19.5% CAGR in the coming years.

    Growing prevalence of cancer and other chronic diseases coupled with the increasing aging population, various initiatives such as the Epidemiology and Genomics Research Program (EGRP), increasing need to understand epigenetic modifications at the molecular level and the advancement of therapeutic solutions are the factors driving the growth of epigenetics market.

    North American market accounted for the largest market share of over 40% in 2020 and is likely to grow at a steady CAGR during the review period.

    Reagents segment garnered the highest market share in 2020 and is likely to register a healthy CAGR during the assessment period.

    Epigenetics treatment companies, Hospitals, Diagnostic Centers And Laboratories, Cancer organizations, Research Centers & Organizations are the target audience in the Epigenetics Market.

    •